The effects of diuretic deprescribing in adult patients: A systematic review to inform an evidence-based diuretic deprescribing guideline.
Autor: | van Poelgeest E; Department of Internal Medicine/Geriatrics, Amsterdam University Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.; Aging and Later Life, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands., Paoletti L; Pharmacy Department, IRCCS San Raffaele Hospital, Milan, Italy., Özkök S; Istanbul Medical Faculty, Department of Internal Medicine, Division of Geriatrics, Capa, Istanbul University, Istanbul, Turkey., Pinar E; Istanbul Medical Faculty, Department of Internal Medicine, Division of Geriatrics, Capa, Istanbul University, Istanbul, Turkey., Bahat G; Istanbul Medical Faculty, Department of Internal Medicine, Division of Geriatrics, Capa, Istanbul University, Istanbul, Turkey., Vuong V; Trillium Health Partners, Mississauga, Ontario, Canada.; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada., Topinková E; Department of Geriatrics, 1st Faculty of Medicine Charles University, Prague, Czech Republic.; General Faculty Hospital, Prague, Czech Republic.; Faculty of Health and Social Sciences, University of South Bohemia, České Budějovice, Czech Republic., Daams J; Medical Library, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., McCarthy L; Trillium Health Partners, Mississauga, Ontario, Canada.; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada., Thompson W; Department of Anesthesiology, Pharmacology, and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada., van der Velde N; Department of Internal Medicine/Geriatrics, Amsterdam University Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.; Aging and Later Life, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands. |
---|---|
Jazyk: | angličtina |
Zdroj: | British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Aug 08. Date of Electronic Publication: 2024 Aug 08. |
DOI: | 10.1111/bcp.16189 |
Abstrakt: | In this systematic review, we report on the effects of diuretic deprescribing compared to continued diuretic use. We included clinical studies reporting on outcomes such as mortality, heart failure recurrence, tolerability and feasibility. We assessed risk of bias and certainty of the evidence using the GRADE framework. We included 25 publications from 22 primary studies (15 randomized controlled trials; 7 nonrandomized studies). The mean number of participants in the deprescribing groups was 35, and median/mean age 64 years. In patients with heart failure, there was no clear evidence that diuretic deprescribing was associated with increased mortality compared to diuretic continuation (low certainty evidence). The risk of cardiovascular composite outcomes associated with diuretic deprescribing was inconsistent (studies showing lower risk for diuretic deprescribing, or comparable risk with diuretic continuation; very low certainty evidence). The effect on heart failure recurrence after diuretic deprescribing in patients with diuretics for heart failure, and of hypertension in patients with diuretics for hypertension was inconsistent across the included studies (low certainty evidence). In patients with diuretics for hypertension, diuretic deprescribing was well tolerated (moderate certainty evidence), while in patients with diuretics for heart failure, deprescribing diuretics can result in complaints of peripheral oedema (very low certainty evidence). The overall risk of bias was generally high. In summary, this systematic review suggests that diuretic discontinuation could be a safe and feasible treatment option for carefully selected patients. However, there isa lack of high-quality evidence on its feasibility, safety and tolerability of diuretic deprescribing, warranting further research. (© 2024 The Author(s). British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.) |
Databáze: | MEDLINE |
Externí odkaz: |